• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术(TIPSS)后血液学改变的前瞻性评估。

Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS).

作者信息

Jalan R, Redhead D N, Allan P L, Hayes P C

机构信息

Centre for Liver and Digestive Diseases, Royal Infirmary of Edinburgh, UK.

出版信息

Eur J Gastroenterol Hepatol. 1996 Apr;8(4):381-5. doi: 10.1097/00042737-199604000-00017.

DOI:10.1097/00042737-199604000-00017
PMID:8781909
Abstract

BACKGROUND

TIPSS is effective in reducing portal hypertension and provides access to the portal system for direct pressure measurements.

OBJECTIVE

To assess the incidence and severity of haemolysis and its course following TIPSS, and also to assess changes in spleen size and any relationship to changes in the platelet and white cell count and haemoglobin concentration.

DESIGN

A prospective study.

MATERIALS AND METHODS

Twenty-three patients undergoing TIPSS with a mean follow-up of 8 months (SE 1.2) were studied. Male-female ratio was 13:10 and the mean age was 53.6 years (SE 1.7). Full blood count, reticulocyte count, serum haptoglobin, urinary haemosiderin, examination of the peripheral blood smear and spleen size (ultrasonography) were measured prior to and 3, 7 and 30 days after TIPSS and 6-monthly thereafter.

RESULTS

Seven patients (30.4%) developed haemolysis, which was clinically significant in three (13%). This settled spontaneously within 2 weeks of TIPSS. Portal pressure gradient was reduced from a mean of 21.9 (SE 1.6) to 9.5 (SE 1) mmHg (P < 0.001) and did not change significantly thereafter. Haemoglobin concentration improved significantly from a mean of 89 (SE 16) to 113 (SE 19) g/l (P < 0.05) after TIPSS. Significant changes in spleen size and platelet count occurred, with a reduction in the former from 16.9 (SE 1.1) to 13.7 cm (SE 2.4) (P < 0.01) and an increase in the latter from 85.9 (SE 8.4) to 135.3 x 10(9)/l (SE 16.8) (P < 0.01). No significant correlations were found between the changes in the portal pressure gradient, spleen size and platelet count. There was no significant change in the white cell count.

CONCLUSION

Transient significant haemolysis occurs in about 13% of patients following TIPSS. TIPSS is useful for reducing splenomegaly and improving thrombocytopenia and haemoglobin. There is no correlation between the changes in portal pressure gradient, spleen size and platelet count.

摘要

背景

经颈静脉肝内门体分流术(TIPSS)在降低门静脉高压方面有效,且可进入门静脉系统进行直接压力测量。

目的

评估TIPSS术后溶血的发生率、严重程度及其病程,同时评估脾脏大小的变化以及与血小板、白细胞计数和血红蛋白浓度变化的关系。

设计

一项前瞻性研究。

材料与方法

对23例行TIPSS的患者进行研究,平均随访8个月(标准误1.2)。男女比例为13:10,平均年龄为53.6岁(标准误1.7)。在TIPSS术前、术后3天、7天、30天以及此后每6个月测量全血细胞计数、网织红细胞计数、血清触珠蛋白、尿含铁血黄素、外周血涂片检查以及脾脏大小(超声检查)。

结果

7例患者(30.4%)发生溶血,其中3例(13%)具有临床意义。溶血在TIPSS术后2周内自发缓解。门静脉压力梯度从平均21.9(标准误1.6)降至9.5(标准误1)mmHg(P<0.001),此后无显著变化。TIPSS术后血红蛋白浓度从平均89(标准误16)显著提高至113(标准误19)g/l(P<0.05)。脾脏大小和血小板计数发生显著变化,前者从16.9(标准误1.1)降至13.7 cm(标准误2.4)(P<0.01),后者从85.9(标准误8.4)升至135.3×10⁹/l(标准误16.8)(P<0.01)。门静脉压力梯度、脾脏大小和血小板计数的变化之间未发现显著相关性。白细胞计数无显著变化。

结论

约13%的患者在TIPSS术后发生短暂的显著溶血。TIPSS有助于减轻脾肿大、改善血小板减少和血红蛋白水平。门静脉压力梯度、脾脏大小和血小板计数的变化之间无相关性。

相似文献

1
Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS).经颈静脉肝内门体分流术(TIPSS)后血液学改变的前瞻性评估。
Eur J Gastroenterol Hepatol. 1996 Apr;8(4):381-5. doi: 10.1097/00042737-199604000-00017.
2
[Hemolytic anemia secondary to the placement of a portosystemic stented shunt].[门静脉系统支架分流术后继发溶血性贫血]
Cir Cir. 2013 Mar-Apr;81(2):143-7.
3
Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease.常发性多囊肾病肝内门体静脉分流术治疗门脉高压的长期疗效。
Dig Liver Dis. 2018 Jul;50(7):707-712. doi: 10.1016/j.dld.2018.03.009. Epub 2018 Mar 15.
4
[Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].经颈静脉肝内门体分流术门静脉系统的临床结果及血流动力学变化
Zhonghua Wai Ke Za Zhi. 1996 May;34(5):303-6.
5
Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.覆膜经颈静脉肝内门体分流术支架比未覆膜支架能维持更低的门静脉压力,且需要更少的再次干预。
Scand J Gastroenterol. 2004 Oct;39(10):994-9. doi: 10.1080/00365520410003443.
6
Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS).
Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1111-6. doi: 10.1097/00042737-199611000-00015.
7
[Influence of transjugular intrahepatic portosystemic stent shunts on portal and systemic hemodynamics of patients with portal hypertension].经颈静脉肝内门体分流术对门静脉高压症患者门静脉及体循环血流动力学的影响
Zhonghua Wai Ke Za Zhi. 1998 Jun;36(6):342-4.
8
Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.经颈静脉肝内门体分流术(TIPSS)治疗40例肝细胞癌患者的疗效与安全性
Aliment Pharmacol Ther. 2015 Jan;41(1):126-36. doi: 10.1111/apt.12994. Epub 2014 Oct 20.
9
[Portal vein thrombosis after occlusion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS). Shunt dilatation with subsequent local and systemic thrombolysis].经颈静脉肝内门体分流术(TIPSS)闭塞后门静脉血栓形成。分流扩张并随后进行局部和全身溶栓治疗
Dtsch Med Wochenschr. 1997 Feb 14;122(7):188-92. doi: 10.1055/s-2008-1047595.
10
Transjugular intrahepatic portosystemic stent-shunt (TIPSS) insertion as a prelude to orthotopic liver transplantation in patients with severe portal hypertension.经颈静脉肝内门体分流术(TIPSS)置入作为严重门静脉高压患者原位肝移植的前奏。
Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1145-9. doi: 10.1097/00042737-199612000-00002.

引用本文的文献

1
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.直接作用抗病毒药物清除 HCV 后血小板减少和白细胞减少的长期变化。
BMC Gastroenterol. 2023 May 25;23(1):182. doi: 10.1186/s12876-023-02829-w.
2
Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study.经颈静脉肝内门体分流术(TIPS)创建后血小板计数的变化:肝脏治疗方法(ALTA)研究组的研究。
J Vasc Interv Radiol. 2023 Aug;34(8):1364-1371. doi: 10.1016/j.jvir.2023.04.015. Epub 2023 Apr 24.
3
Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt.
经颈静脉肝内门体分流术后腹腔镜脾切除术治疗门静脉高压继发脾功能亢进的疗效及安全性
BMC Gastroenterol. 2021 Feb 11;21(1):61. doi: 10.1186/s12876-021-01647-2.
4
Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review.慢性丙型肝炎病毒感染中血小板减少症的发病机制:综述
J Clin Transl Hepatol. 2020 Jun 28;8(2):184-191. doi: 10.14218/JCTH.2020.00007. Epub 2020 Apr 15.
5
The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.经颈静脉肝内门体分流术对肝硬化患者血小板计数的影响
Gastroenterol Hepatol (N Y). 2017 May;13(5):286-291.
6
Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.覆膜经颈静脉肝内门体分流术不能改善肝硬化患者的血小板减少症。
Dig Dis Sci. 2012 Sep;57(9):2430-7. doi: 10.1007/s10620-012-2162-z. Epub 2012 May 16.
7
Abnormal hematological indices in cirrhosis.肝硬化患者的血液学指标异常。
Can J Gastroenterol. 2009 Jun;23(6):441-5. doi: 10.1155/2009/591317.